Advertisement FDA allows Actavis to market generic Aricept in US - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

FDA allows Actavis to market generic Aricept in US

The US Food and Drug Administration (FDA) has given marketing approval to Actavis' Donepezil Hydrochloride Tablets, a generic equivalent of Aricept, in the US.

Aricept (donepezil HCl) is a prescription medicine to treat mild, moderate and severe Alzheimer’s disease.

Actavis is a pharmaceutical company specializing in the development, manufacture and sale of generic pharmaceuticals.

Based in Morristown, NJ, Actavis has operations in 40 countries, with more than 10,500 employees.